CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

Conditions:   Sarcoma, Ewing;   Neoplasm Metastasis Interventions:   Drug: Abemaciclib;   Drug: Irinotecan;   Drug: Temozolomide Sponsor:   Eli Lilly and Company Not yet recruiting

Source: ClinicalTrials.gov - July 1, 2022 Category: Research Source Type: clinical trials